相关实验视频

Updated: Jul 8, 2025

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

A Method to Study the C924T Polymorphism of the Thromboxane A2 Receptor Gene

Published on: April 1, 2019

EPCR基因p.Ser219Gly多态化与静脉血栓塞栓症风险之间的关联:病例对照研究,元分析和可重现性研究

Dóra Pituk¹, Tünde Miklós², Ágota Schlammadinger³

¹Division of Clinical Laboratory Sciences, Department of Laboratory Medicine, Faculty of Medicine, Kálmán Laki Doctoral School, University of Debrecen, Debrecen, Hungary.

Frontiers in cardiovascular medicine

|December 11, 2023

概括

在PROCR基因中的rs867186多态性与初始静脉血栓塞栓症 (VTE) 风险无关,但显示出VTE复发的趋势. 这一发现有助于个性化的VTE风险评估和患者管理.

科学领域:

遗传学是一个遗传学.
分子生物学分子生物学
流行病学流行病学

背景情况:

在PROCR基因中的rs867186单核酸多态性 (SNP) 导致内皮蛋白C受体 (EPCR) 的219号代号的血清蛋白替换为甘氨酸.
这项研究调查了rs867186多态和静脉血栓栓塞 (VTE) 风险之间的关联.

研究的目的:

进行一项病例控制研究和更新的元分析,研究PROCR rs867186多态和VTE风险之间的关联.
评估MetaGenyo软件在遗传流行病学中进行元分析的实用性.

主要方法:

一项涉及263名VTE患者和320名健康对照者的病例控制研究.
一个更新的元分析,结合了使用MetaGenyo软件的5,768个病例和30,017个对照的数据.
一项可重现性研究,以验证元分析结果.

主要成果:

在病例控制研究中,rs867186的多态性并没有显著影响VTE的风险 (OR 1.339;95%CI:0.904-1.984).
在rs867186多态的携带者中观察到VTE复发的趋势 (OR 1.72;95%CI:0.95-3.13).
分析显示,在多个模型中,EPCR Ser219Gly多态和VTE之间存在显著的关联 (例如,主导模型OR=1.27,p=0.0006).

结论:

rs867186多态性与VTE的初始风险无关,但可能与VTE复发有关.
在遗传流行病学研究中的元分析中,MetaGenyo软件被认为是可以接受的.
识别rs867186小等位基因的载体可以为个性化的VTE风险评估和管理做出贡献.

关键词:

这就是 PROCR 基因.在Ser219Gly的基础上.内皮蛋白C受体内皮蛋白C受体这是一个元分析.多形态主义的多态主义.其他: rs867186 一个单核酸的核酸.静脉血栓的形成静脉血栓的形成

更多相关视频

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

High-resolution Melting PCR for Complement Receptor 1 Length Polymorphism Genotyping: An Innovative Tool for Alzheimer's Disease Gene Susceptibility Assessment

Published on: July 18, 2017

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay EMSA and DNA-affinity Precipitation Assay DAPA

Published on: August 21, 2016

相关概念视频

Single Nucleotide Polymorphisms-SNPs

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...

Genome-wide Association Studies-GWAS

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...

Comparing Copy Number Variations and SNPs

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...